{
  "info": {
    "company_name": "argenx SE",
    "company_url": "https://www.responsibilityreports.com/Company/argenx-se",
    "ticker_name": "ARGX",
    "exchange": "NASDAQ",
    "industry": "Biotechnology",
    "sector": "Healthcare",
    "about_company": "argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx is translating immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx is evaluating efgartigimod in multiple serious\u2026More",
    "num_employees": "501-1000 Employees",
    "location": "Based in Ghent, Belgium"
  },
  "reports": [
    {
      "pdf_url": "https://www.responsibilityreports.com/HostedData/ResponsibilityReports/PDF/NASDAQ_ARGX_2021.pdf",
      "report_name": "NASDAQ_ARGX_2021"
    }
  ]
}